UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000042441
Receipt No. R000048427
Scientific Title Epidemic research to assess health disparities
Date of disclosure of the study information 2020/11/16
Last modified on 2020/11/13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Research to assess health disparities
Acronym Research about health disparities
Scientific Title Epidemic research to assess health disparities
Scientific Title:Acronym Epidemic research about health disparities
Region
Japan

Condition
Condition Healthy controls, allergic diseases, et cetera.
Classification by specialty
Medicine in general Pneumology Clinical immunology
Pediatrics Child
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To assess health disparities
Basic objectives2 Others
Basic objectives -Others To assess health disparities in infancy and childhood
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Health disparities
Key secondary outcomes The relationship between clinical factors and diseases including allergic diseases in infancy and childhood.
The relationship between allergic rhinitis, asthma, and atopic dermatitis.
The relationship between first milk and allergic diseases, etc.

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
1 years-old <=
Age-upper limit
16 years-old >
Gender Male and Female
Key inclusion criteria Children born in 2001 and 2010
Key exclusion criteria Those who do not consent with this study.
Target sample size 80000

Research contact person
Name of lead principal investigator
1st name Takahiro
Middle name
Last name Tabuchi
Organization Osaka International Cancer Institute
Division name Cancer Control Center
Zip code 541-8567
Address 1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan
TEL +81-6-6945-1181
Email tabuchitak@gmail.com

Public contact
Name of contact person
1st name Takahiro
Middle name
Last name Tabuchi
Organization Osaka International Cancer Institute
Division name Cancer Control Center
Zip code 541-8567
Address 1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan
TEL +81-6-6945-1181
Homepage URL
Email tabuchitak@gmail.com

Sponsor
Institute Osaka International Cancer Institute
Institute
Department

Funding Source
Organization Ministry of education, culture, sports, science and technology
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka International Cancer Institute
Address 1-69, Ohtemae 3-Chome, Chuo-ku, Osaka, 541-8567 Japan
Tel +81-6-6945-1181
Email rinri01@opho.jp

Secondary IDs
Secondary IDs YES
Study ID_1 1508119060
Org. issuing International ID_1 Osaka International Cancer Institute
Study ID_2 1508119060-2
Org. issuing International ID_2 Osaka International Cancer Institute
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 11 Month 16 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled 85564
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2000 Year 07 Month 15 Day
Date of IRB
2015 Year 01 Month 08 Day
Anticipated trial start date
2001 Year 01 Month 01 Day
Last follow-up date
2024 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Observational study

Management information
Registered date
2020 Year 11 Month 13 Day
Last modified on
2020 Year 11 Month 13 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048427

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.